Statement Of Cash Flows [Abstract]

Captor Therapeutics S.A. - Filing #6226332

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-01-01
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations
13 496 417 PLN
57 435 477 PLN
Cash flows from (used in) operating activities
13 496 417 PLN
57 435 477 PLN
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
18 823 380 PLN
8 579 410 PLN
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
4 838 680 PLN
0 PLN
Payments of lease liabilities, classified as financing activities
728 186 PLN
1 435 569 PLN
Proceeds from government grants, classified as financing activities
8 238 898 PLN
21 852 452 PLN
Interest paid, classified as financing activities
51 024 PLN
31 483 PLN
Cash flows from (used in) financing activities
13 856 788 PLN
20 448 366 PLN
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
18 463 009 PLN
86 463 253 PLN
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
0 PLN
0 PLN
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
18 463 009 PLN
86 463 253 PLN
Cash and cash equivalents
102 039 315 PLN
120 502 324 PLN
34 039 071 PLN

Talk to a Data Expert

Have a question? We'll get back to you promptly.